Tomas Hanke PhD

University of Oxford

Appearances

A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection
A NOVEL CONSERVED-REGION T-CELL MOSAIC VACCINE WITH VERY GLOBALE COVERAGE OF HIV-1 VARIANTS IS RECOGNIZED BY PROTECTIVE RESPONSES IN CHRONIC UNTREATED INFECTION
Speaker
Tomas Hanke, PhD
University of Oxford
Free
Standard Price

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.